- Home
- LAUR vs LNTH Comparison
LAUR vs LNTH Comparison
Compare LAUR & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAUR
- LNTH
- Stock Information
- Founded
- LAUR 1989
- LNTH 1956
- Country
- LAUR United States
- LNTH United States
- Employees
- LAUR N/A
- LNTH N/A
- Industry
- LAUR Other Consumer Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LAUR Real Estate
- LNTH Health Care
- Exchange
- LAUR Nasdaq
- LNTH Nasdaq
- Market Cap
- LAUR 3.5B
- LNTH 3.6B
- IPO Year
- LAUR 2017
- LNTH 2015
- Fundamental
- Price
- LAUR $27.62
- LNTH $55.12
- Analyst Decision
- LAUR Buy
- LNTH Strong Buy
- Analyst Count
- LAUR 1
- LNTH 6
- Target Price
- LAUR $24.00
- LNTH $105.50
- AVG Volume (30 Days)
- LAUR 837.7K
- LNTH 1.9M
- Earning Date
- LAUR 10-30-2025
- LNTH 08-06-2025
- Dividend Yield
- LAUR N/A
- LNTH N/A
- EPS Growth
- LAUR 35.40
- LNTH N/A
- EPS
- LAUR 1.68
- LNTH 3.77
- Revenue
- LAUR $1,552,343,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- LAUR $5.64
- LNTH N/A
- Revenue Next Year
- LAUR $8.10
- LNTH $3.24
- P/E Ratio
- LAUR $16.46
- LNTH $14.27
- Revenue Growth
- LAUR 0.44
- LNTH 5.75
- 52 Week Low
- LAUR $14.45
- LNTH $47.25
- 52 Week High
- LAUR $28.16
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- LAUR 71.98
- LNTH 38.66
- Support Level
- LAUR $26.87
- LNTH $53.10
- Resistance Level
- LAUR $28.16
- LNTH $55.69
- Average True Range (ATR)
- LAUR 0.52
- LNTH 1.85
- MACD
- LAUR 0.02
- LNTH 0.60
- Stochastic Oscillator
- LAUR 76.65
- LNTH 27.65
About LAUR Laureate Education Inc.
Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its geographical segments include Peru and Mexico.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.